Table 1.
A 48 h treatment with neutral sphingomyelinase, C2- and C8-ceramide, but not with the inactive analogue C2-dihydroceramide, reduces the incorporation of [3H]-thymidine in LNCaP cells
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.